HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[SOS1 mutation: a new cause of Noonan syndrome].

Abstract
Noonan syndrome, characterized by short stature, facial anomalies, heart disease and cryptorchidism in males, is an autosomal dominant, genetically heterogeneous disease. Approximately 50 % of Noonan syndrome cases are caused by gain-of-function mutations in PTPN11, encoding the tyrosine phosphatase (SHP2) and 5 % are caused by KRAS mutations. Recently, a new mutation in SOS1 gene has been identified in approximately 20 % of cases of Noonan syndrome without PTPN11 mutation. That difference in genotype has a relationship with phenotype that we must investigate. We report a case of Noonan syndrome due to an SOS1 mutation; we describe his phenotype and subsequent outcome.
AuthorsM M Serrano-Martín, M J Martínez-Aedo, M Tartaglia, J P López-Siguero
JournalAnales de pediatria (Barcelona, Spain : 2003) (An Pediatr (Barc)) Vol. 68 Issue 4 Pg. 365-8 (Apr 2008) ISSN: 1695-4033 [Print] Spain
Vernacular TitleMutación en el gen SOS1 como nueva causa de síndrome de Noonan.
PMID18394382 (Publication Type: Case Reports, English Abstract, Journal Article)
Chemical References
  • SOS1 Protein
  • PTPN11 protein, human
  • Protein Tyrosine Phosphatase, Non-Receptor Type 11
Topics
  • Adolescent
  • Humans
  • Male
  • Noonan Syndrome (genetics)
  • Phenotype
  • Point Mutation (genetics)
  • Protein Tyrosine Phosphatase, Non-Receptor Type 11 (genetics)
  • SOS1 Protein (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: